Identification of TRIM23 as a cofactor involved in the regulation of NF-κB by human cytomegalovirus

Journal of Virology

Volumn 83, Issue 8, 2009, Pages 3581-3590

  Poole, Emma ^a   Groves, Ian ^a   Macdonald, Andrew ^c   Pang, Yin ^a   Alcami, Antonio ^a,b   Sinclair, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; TRIPARTITE MOTIF 23 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UL144 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; TRIM23 PROTEIN, HUMAN; UL144 ORF PROTEIN, HUMAN HERPESVIRUS 5;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CYTOMEGALOVIRUS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

HUMAN HERPESVIRUS 5;

CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; GTP-BINDING PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PROTEIN BINDING; TNF RECEPTOR-ASSOCIATED FACTOR 6; VIRAL PROTEINS;

EID: 64049092850     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02072-08     Document Type: Article

References (44)

1. Amici, C., G. Belardo, A. Rossi, and M. G. Santoro. 2001. Activation of IκB kinase by herpes simplex virus type 1: a novel target for anti-herpetic therapy. J. Biol. Chem. 276:28759-28766.
2. Baillie, J., D. A. Sahlender, and J. H. Sinclair. 2003. Human cytomegalovirus infection inhibits tumor necrosis factor (TNF) alpha signaling by targeting the 55-kilodalton TNF receptor. J. Virol. 77:7007-7016. (Pubitemid 36666893)
3. Bloor, S., G. Ryzhakov, S. Wagner, P. J. Butler, D. L. Smith, R. Krumbach, I. Dikic, and F. Randow. 2008. Signal processing by its coiled coil zipper domain activates IKKγ. Proc. Natl. Acad. Sci. USA 105:1279-1284.
4. Cha, T. A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83. (Pubitemid 126508771)
5. Chan, G., E. R. Bivins-Smith, M. S. Smith, and A. D. Yurochko. 2008. Transcriptome analysis of NF-κB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J. Virol. 82:1040-1046.
6. DeMeritt, I. B., L. E. Milford, and A. D. Yurochko. 2004. Activation of the NF-κB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J. Virol. 78:4498-4507. (Pubitemid 38501069)
7. DeMeritt, I. B., J. P. Podduturi, A. M. Tilley, M. T. Nogalski, and A. D. Yurochko. 2006. Prolonged activation of NF-κB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 346:15-31.
8. Dunn, W. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 100:14223-14228.
9. Everett, R. D., C. Parada, P. Gripon, H. Sirma, and A. Orr. 2008. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J. Virol. 82:2661-2672.
10. Gack, M. U., Y. C. Shin, C. H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
11. + T cells. J. Gen. Virol. 86:275-284.
12. Goodkin, M. L., S. Epstein, P. A. Asbell, and J. A. Blaho. 2007. Nuclear translocation of NF-κB precedes apoptotic poly(ADP-ribose) polymerase cleavage during productive HSV-1 replication in corneal epithelial cells. Investig. Ophthalmol. Vis Sci. 48:4980-4988.
13. Goodkin, M. L., E. R. Morton, and J. A. Blaho. 2004. Herpes simplex virus infection and apoptosis. Int. Rev. Immunol. 23:141-172. (Pubitemid 38121750)
14. Goodkin, M. L., A. T. Ting, and J. A. Blaho. 2003. NF-κB is required for apoptosis prevention during herpes simplex virus type 1 infection. J. Virol. 77:7261-7280. (Pubitemid 36734495)
15. Gregory, D., D. Hargett, D. Holmes, E. Money, and S. L. Bachenheimer. 2004. Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway. J. Virol. 78:13582-13590. (Pubitemid 39612758)
16. Hahn, G., M. G. Revello, M. Patrone, E. Percivalle, G. Campanini, A. Sarasini, M. Wagner, A. Gallina, G. Milanesi, U. Koszinowski, F. Baldanti, and G. Gerna. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033. (Pubitemid 39187120)
17. Hargett, D., S. Rice, and S. L. Bachenheimer. 2006. Herpes simplex virus type 1 ICP27-dependent activation of NF-κB. J. Virol. 80:10565-10578. (Pubitemid 44628903)
18. Ishitani, T., G. Takaesu, J. Ninomiya-Tsuji, H. Shibuya, R. B. Gaynor, and K. Matsumoto. 2003. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22:6277-6288. (Pubitemid 37522585)
19. Jackson-Bernitsas, D. G., H. Ichikawa, Y. Takada, J. N. Myers, X. L. Lin, B. G. Darnay, M. M. Chaturvedi, and B. B. Aggarwal. 2007. Evidence that the TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26:1385-1397.
20. Kaspari, M., N. Tavalai, T. Stamminger, A. Zimmermann, R. Schilf, and E. Bogner. 2008. Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus. FEBS Lett. 582:666-672.
21. Liu, H., C. C. Wu, and Y. S. Chang. 2006. PRA1 promotes the intracellular trafficking and NF-κB signaling of EBV latent membrane protein 1. EMBO J. 25:4120-4130. (Pubitemid 44338752)
22. Murphy, E., I. Rigoutsos, T. Shubuya, and T. E. Shenk. 2003. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. USA 100:13585-13590.
23. Nakayama, T., K. Hieshima, D. Nagakubo, E. Sato, M. Nakayama, K. Kawa, and O. Yoshie. 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol. 78:1665-1674. (Pubitemid 38176699)
24. Pass, R. 2001. Cytomegalovirus, p. 2675-2705. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, PA.
25. Patel, A., J. Hanson, T. I. McLean, J. Olgiate, M. Hilton, W. E. Miller, and S. L. Bachenheimer. 1998. Herpes simplex type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication. Virology 247:212-222.
26. Poole, E., E. Atkins, T. Nakayama, O. Yoshie, I. Groves, A. Alcami, and J. Sinclair. 2008. NF-κB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J. Virol. 82:4250-4256.
27. Poole, E., B. He, R. A. Lamb, R. E. Randall, and S. Goodbourn. 2002. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303:33-46.
28. Poole, E., C. King, J. Sinclair, and A. Alcami. 2006. The UL144 gene product of human cytomegalovirus activates NF-κB via a TRAF6-dependent mechanism. EMBO J. 25:4390-4399. (Pubitemid 44435236)
29. Poole, E., P. Strappe, H. P. Mok, R. Hicks, and A. M. L. Lever. 2005. HIV-1 gag-RNA interaction occurs at a perinuclear/centrosomal site: analysis by confocal microscopy and FRET. Traffic 6:1-15.
30. Prichard, M. N., M. E. Penfold, G. M. Duke, R. R. Spaete, and G. W. Kemble. 2001. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11:191-200. (Pubitemid 32510202)
31. Schultheiss, U., S. Puschner, E. Kremmer, T. W. Mak, H. Engelmann, W. Hammerschmidt, and A. Kieser. 2001. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20:5678-5691. (Pubitemid 33010045)
32. Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun. 2008. TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9:369-377.
33. Song, Y.-L., K.-Y. Jen, V. Soni, E. Kieff, and E. Cahir-McFarland. 2006. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-κB activation. Proc. Natl. Acad. Sci. USA 103:2689-2694.
34. Tavalai, N., P. Papior, S. Rechter, and T. Stamminger. 2008. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82:126-137. (Pubitemid 350309130)
35. Taylor, R. T., and W. A. Bresnahan. 2006. Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFκB-dependent gene expression. J. Virol. 80:10763-10771. (Pubitemid 44628922)
36. Tomasec, P., E. C. Wang, A. J. Davison, B. Vojtesek, M. Armstrong, C. Griffin, B. P. McSharry, R. J. Morris, S. Llewellyn-Lacey, C. Rickards, A. Nomoto, C. Sinzger, and G. W. Wilkinson. 2005. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6:181-188. (Pubitemid 40268199)
37. Uemura, N., T. Kajino, H. Sanjo, S. Sato, S. Akira, K. Matsumoto, and J. Ninomiya-Tsuji. 2006. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-κB. J. Biol. Chem. 281:7863-7872. (Pubitemid 43847402)
38. Vichi, A., D. M. Payne, G. Pacheco-Rodriguez, J. Moss, and M. Vaughan. 2005. E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). Proc. Natl. Acad. Sci. USA 102:1945-1950.
39. Wang, W., S. L. Taylor, S. A. Leisenfelder, R. Morton, J. F. Moffat, S. Smirnov, and H. Zhu. 2005. Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice. J. Virol. 79:2115-2123. (Pubitemid 40204569)
40. Wills, M. R., O. Ashiru, M. B. Reeves, G. Okecha, J. Trowsdale, P. Tomasec, G. W. Wilkinson, J. Sinclair, and J. G. Sissons. 2005. Human cytomegalovirus encodes an MHC class-I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175:7457-7465. (Pubitemid 41713443)
41. Wu, L., H. Nakano, and Z. Wu. 2006. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-κB through TRAF6 and TAK1. J. Biol. Chem. 281:2162-2169.
42. Yap, M. W., M. P. Dodding, and J. P. Stoye. 2006. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. J. Virol. 80:4061-4067.
43. Yu, Q., Y. Minoda, R. Yoshida, H. Yoshida, H. Iha, T. Kobayashi, A. Yoshimura, and G. Takaesu. 2008. HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein. Biochem. Biophys. Res. Commun. 365:189-194. (Pubitemid 350110575)
44. Yurochko, A. D. 2008. Human cytomegalovirus modulation of signal transduction. Curr. Top. Microbiol. Immunol. 325:205-220.